Saturday, August 18, 2018

Latest:

Is there really a perfect way to study humans?
From the labs to commercialization: Companies merge to implement Baylor College of Medicine-developed therapies for cancer
Throwback Thursday: Don’t Turn Around…
What is cognitive behavioral therapy?
Healthy fat cells uncouple obesity from diabetes

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
GoWoman
bcm.edu

lysosome

From The Labs

USP15 could be a target in ovarian cancer scientists have been looking for

May 8, 2018May 8, 2018 Ana Rodríguez 1 Comment lysosome, ovarian cancer, ovarian steroids, p53, p53-R175H, proteasome, Research, steroid receptor coactivator, USP 15

Ovarian cancer is currently treated with surgery and chemotherapy. Chemotherapy for ovarian cancer is based on drugs that act on

From The Labs Image of the Month

From The Labs features the cytoplasmic distribution of p53-R175H mutant protein (green) in TYK-Nu ovarian cancer cells that have been treated with the drug MCB-613. Read more.